+49 30 648 35 164 service@chameleon-pharma.com

Colombia banning animal testing in cosmetics. How can this positively impact your business abroad?

Being the first country in Latin America to create public policies on this matter, Colombia will probably influence its neighboring countries to move in the same direction which can have a positive impact on your business.

In a historical decision, the Colombian Congress approved a law that bans animal testing for cosmetics and personal care products. The text, to be signed by President Ivan Duque, prohibits “the experimentation, import, export, manufacture, and marketing of cosmetic products, their ingredients or combinations of them” that have been tested on animals after its entry into force. This new law, however, does not affect animal testing for medical purposes.

In addition to financial penalties, the new legislation supports campaigns against testing cosmetics on animals, and incentives for laboratories that develop and apply alternative testing models. Companies will have four years to adapt their processes to comply with the new law.

This law will heavily affect trade with countries where animal testing is mandatory, such as China for example. On the other hand, this can be particularly interesting for companies interested in a market entry in Columbia, and can even facilitate trade with the European market, where a law similar to the Colombian one already applies.

Being the 3rd most important beauty and personal care market in Latin America, sales in Colombia are expected to reach US$5,14 million by 2030. We can help you build a solid market entry strategy to take advantage of this opportunity or support you in product registration. Click here for more information.

Featured image: Photo by Towfiqu barbhuiya on Unsplash

Contact us

14 + 13 =

Related Posts

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis